All stocks Β· ZOTA
ZH

Zota Health Care LImited

ZOTA NSE Biotechnology Healthcare

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic …

ISIN INE358U01012
Listed 19 Aug 2019
Quarters tracked 13
Filings 12 docs

About

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

Key Metrics

as of Sep 2026
Market Cap3,922 Cr
P/Eβ€”
Div Yield0.09 %
Book Valueβ‚Ή200.00
52w Highβ‚Ή1,740.00
52w Lowβ‚Ή1,022.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 174.00 163.00 143.00 129.00 104.00 97.00 72.00 67.00 56.00 50.00 47.00 45.00 39.00
Expenses 185.00 154.00 143.00 123.00 100.00 95.00 78.00 68.00 58.00 51.00 44.00 41.00 37.00
Operating Profit -12.00 9.00 0.00 6.00 4.00 2.00 -6.00 -1.00 -1.00 -1.00 3.00 4.00 1.00
OPM % -7.00 5.00 -0.30 4.90 3.80 2.50 -8.00 -1.30 -2.20 -3.00 7.00 10.00 3.30
Other Income 2.00 -3.00 2.00 2.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00
Depreciation 28.00 27.00 22.00 19.00 15.00 14.00 11.00 10.00 8.00 7.00 5.00 5.00 3.00
Interest 6.00 5.00 5.00 4.00 3.00 3.00 2.00 3.00 3.00 2.00 1.00 1.00 1.00
Profit before tax -44.00 -26.00 -26.00 -14.00 -13.00 -14.00 -18.00 -13.00 -12.00 -10.00 -3.00 -1.00 -3.00
Tax % 1.00 -45.00 14.00 13.00 5.00 -10.00 2.00 -4.00 5.00 -27.00 7.00 49.00 1.00
Net Profit -44.00 -14.00 -30.00 -16.00 -14.00 -13.00 -19.00 -12.00 -13.00 -7.00 -3.00 -2.00 -3.00
EPS in Rs -12.58 -4.09 -8.73 -5.20 -4.81 -4.50 -6.78 -4.41 -4.79 -2.68 -1.14 -0.64 -1.13

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2015Mar 2014Mar 2012Mar 2011
Sales 539.00292.00180.00139.00131.00106.0095.0085.0056.0050.0038.0025.00
Expenses 520.00298.00173.00132.00116.00105.0090.0077.0047.0043.0033.0021.00
Operating Profit 19.00-6.008.007.0015.001.005.008.008.006.005.004.00
OPM % 3.40-2.004.205.0011.000.604.809.0015.0013.0013.0014.00
Other Income 1.002.001.002.002.002.002.002.000.000.000.000.00
Interest 17.0011.005.003.000.000.000.000.001.001.001.000.00
Depreciation 82.0043.0020.0012.004.003.002.001.002.001.001.000.00
Profit before tax -80.00-58.00-16.00-5.0012.000.004.008.006.005.003.003.00
Tax % -7.00-2.00-11.0023.0028.00-41.0029.0029.0033.0033.0033.0034.00
Net Profit -74.00-57.00-14.00-6.009.000.003.006.004.003.002.002.00
EPS in Rs -21.35-19.70-5.55-2.293.54-0.091.122.262.121.851.432.17
Dividend Payout % -5.00-5.00-18.00-44.0042.00-1,170.0090.0032.0034.0038.0050.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2015Mar 2014Mar 2012Mar 2011
Equity Capital 35.0029.0026.0025.0025.0025.0025.0018.0014.0012.0010.007.00
Reserves 659.00195.0064.0055.0064.0042.0044.0051.004.004.003.005.00
Borrowings 270.00140.0095.0045.0015.000.000.000.005.005.006.003.00
Other Liabilities 167.0076.0043.0033.0035.0019.0020.0021.0017.0014.0010.005.00
Total Liabilities 1,131.00439.00228.00158.00139.0085.0088.0090.0040.0035.0029.0020.00
Fixed Assets 383.00185.00103.0062.0029.0014.0015.0010.008.009.0010.008.00
CWIP 2.006.005.003.000.000.000.002.000.000.000.000.00
Investments 264.0054.005.008.0033.0010.0014.0016.000.000.000.000.00
Other Assets 483.00193.00116.0085.0077.0061.0059.0063.0032.0026.0019.0012.00
Total Assets 1,131.00439.00228.00158.00139.0085.0088.0090.0040.0035.0029.0020.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2015Mar 2014
Cash from Operating Activity -84.00-50.00-6.00-2.0013.00-1.006.00-3.005.003.00
Cash from Investing Activity -314.00-92.00-13.0015.00-27.004.00-4.009.00-1.00-1.00
Cash from Financing Activity 490.00145.0019.00-14.0014.00-2.00-3.00-6.00-4.00-2.00
Net Cash Flow 92.003.000.00-1.001.001.00-1.00-1.000.000.00
Free Cash Flow -197.00-96.00-23.00-13.0010.00-2.00-1.00-6.004.002.00
CFO/OP % -394.00811.00-59.002.00115.00-134.00147.00-12.0081.0078.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2015Mar 2014Mar 2012Mar 2011
Debtor Days 50.0051.0055.0073.00102.0099.00112.0095.0077.0079.0071.0075.00
Inventory Days 329.00277.00201.00183.00121.00140.00139.00208.00175.00134.00141.00122.00
Days Payable 178.00111.00126.00116.0078.0077.0082.00104.000.000.0090.0077.00
Cash Conversion Cycle 200.00217.00131.00140.00145.00161.00169.00199.00251.00212.00123.00120.00
Working Capital Days 84.00100.0075.00111.00108.00143.00152.00175.0080.0078.0070.00102.00
ROCE % -8.00-17.00-7.00-2.0015.00-2.006.00β€”32.00β€”20.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 49.38 49.38 50.64 55.81 57.42 59.72 62.02 62.40 64.44 66.15 66.15 66.16
FIIs 7.92 8.21 8.09 3.49 3.82 0.87 0.24 0.01 0.01 0.00 0.00 0.02
DIIs 6.75 6.40 7.22 4.95 4.25 3.08 1.03 0.99 0.00 0.00 0.00 0.00
Public 35.96 36.00 34.06 35.75 34.52 36.33 36.71 36.60 35.55 33.85 33.85 33.83
No. of Shareholders 14,678 14,005 13,185 11,855 10,354 10,389 9,763 8,937 7,661 7,435 7,589 7,285

Corporate Actions

7 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 22 Sep 2025 22 Sep 2025 β€” 1.00
Dividend 20 Sep 2024 21 Sep 2024 β€” 1.00
Dividend 22 Sep 2023 β€” β€” 1.00
Dividend 19 Sep 2022 β€” β€” 1.50
Dividend 22 Sep 2021 β€” β€” 1.00
Dividend 17 Sep 2020 β€” β€” 1.00
Dividend 12 Sep 2019 β€” β€” 1.00

Announcements

5 filings
  • Copy of Newspaper Publication
    04 Sep 2026 4 Sep - Newspaper advertisements published for Zota Health Care’s 26th AGM on September 28, 2026.
  • Appointment
    03 Sep 2026 3 Sep - Board approved Sept 28 AGM, 10% dividend, Sept 21 record date, and material RPTs up to β‚Ή100 crore.
  • Outcome of Board Meeting
    03 Sep 2026 3 Sep - Board approved 26th AGM on Sept 28, 2026, 10% final dividend, and director appointments.
  • Record Date
    03 Sep 2026 3 Sep - Record date set for final dividend and 26th AGM on September 21, 2026.
  • Shareholders meeting
    03 Sep 2026 3 Sep - Board approved 26th AGM on September 28, 2026, 10% final dividend, Mahaveer Dhariwal appointment, and MD reappointment.